Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 854 for phase
Company Exchange Symbol Last price Quote change Market cap
Amgen, Inc. NASDAQ AMGN 163.46 +2.79 (1.74%) 124.34B
... primarily in the United States in cancer care, inflammation, nephrology and bone disease. As of February 17, 2014, the Company has 16 Phase III programs.
Inovio Pharmaceuticals Inc NASDAQ INO 9.36 +0.25 (2.74%) 567.13M
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious ...
Gilead Sciences, Inc. NASDAQ GILD 93.79 +2.50 (2.74%) 141.50B
Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines.
Eli Lilly and Co NYSE LLY 70.39 +0.23 (0.33%) 78.37B
The Company's new molecular entities (NMEs) are in Phase III clinical trial testing include Dulaglutide, Edivoxetine, Empagliflozin-BI10773, Enzastaurin, ...
AbbVie Inc NYSE ABBV 66.98 +0.77 (1.16%) 106.73B
... including more than 20 compounds or indications in Phase II or Phase III development across medical specialties as immunology, virology/liver disease, ...
AstraZeneca plc (ADR) NYSE AZN 70.91 +0.47 (0.67%) 89.29B
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas ...
GlaxoSmithKline plc (ADR) NYSE GSK 43.15 +0.30 (0.70%) 104.55B
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of ...
CTI BioPharma Corp NASDAQ CTIC 2.40 +0.04 (1.69%) 381.82M
... or refractory aggressive non-Hodgkin lymphoma (NHL), and conducting a Phase III clinical trial of pacritinib for the treatment of myelofibrosis.
AstraZeneca plc LON AZN 4,555.50 +39.00 (0.86%) 57.78B
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas ...
Novartis AG (ADR) NYSE NVS 94.10 +0.19 (0.20%) 254.06B
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and ...
Baxter International Inc. NYSE BAX 74.56 +0.11 (0.15%) 40.41B
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets ...
Seattle Genetics, Inc. NASDAQ SGEN 32.00 +0.90 (2.89%) 3.96B
Seattle Genetics, Inc. is biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer.
Novavax, Inc. NASDAQ NVAX 5.92 +0.11 (1.89%) 1.41B
Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines.
GlaxoSmithKline plc LON GSK 1,385.00 0.00 (0.00%) 67.36B
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of ...
Novartis AG VTX NOVN 92.35 -1.20 (-1.28%) 249.99B
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and ...
Celldex Therapeutics, Inc. NASDAQ CLDX 18.24 +1.16 (6.79%) 1.63B
Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies ...
Sanofi SA (ADR) NYSE SNY 46.15 -0.20 (-0.43%) 121.11B
As of February 2011, Sanofi portfolio comprised 55 projects in clinical development, of which 13 were in Phase III or had been submitted to the health ...
Nektar Therapeutics NASDAQ NKTR 15.23 +0.20 (1.36%) 1.96B
Its drug candidate, naloxegol (formerly known as NKTR-118), is an oral opioid antagonist, which has completed Phase III clinical studies for the treatment ...
Astellas Pharma Inc TYO 4503 1,724.50 +11.50 (0.67%) 3.89T
Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of ...
Ligand Pharmaceuticals Inc. NASDAQ LGND 52.96 +1.17 (2.26%) 1.04B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.